N/A N=68 Preventing Medication Dispensing Errors in Pharmacy Practice With Interpretable Machine Intelligence
Machine Intelligence in the Pharmacy
Primary: Reaction Time — 3668; 4727; 4510 millisecond (ms)
Clinical Trial Search
Completed trials with posted results — search by concept, filter by the parameters that matter at the bedside.
N/A N=306 Pharmacists and Pharmacy Technicians to Improve Admission Medication History Accuracy
Adverse Drug Events
Primary: Mean Severity-weighted Admission Medication History (AMH) Error Score — 23; 4.1; 4.1 Mean Severity-weighted AMH Error Score
N/A N=58 VA Integrated Medication Manager
Electronic Health Records
Primary: Amount of Time to Complete Assessment and Plan — 8.5; 8.7 minutes — p=0.047
N/A N=5,421 Medication Adherence Clinical Decision Support
Hyperlipidemia · Hypertension · Diabetes
Primary: Blood Pressure Medication Adherence — 396; 470 Participants — p=0.0103
N/A N=31,432 Data-driven Identification for Substance Misuse
Substance Use · Substance Abuse · Substance-Related Disorders
Primary: Proportion of Patients That Had a Universal Screen Positive and Received SBIRT (Screening, Brief Intervention, or Referral to Treatment) — 1189; 1144 Participants — p=0.20
N/A N=396 Achieving Medication Safety During Acute Kidney Injury
Kidney Failure, Acute
Primary: Adverse Drug Events or Potential Adverse Drug Events — 99; 104 Patient-Medication Pairs
N/A N=355 Assessing the Performance of Artificial Intelligence (AI)-Augmented Electronic Health Record (EHR) Data Abstraction for Clinical Trial Patient Screening
Cancer
Primary: Abstracted Chart-level Accuracy — 76.10; 71.48; 59.92 % of elements correctly abstracted — p=<0.001
N/A N=190 Delivery of Pharmacogenetic Testing in a Community Pharmacy Setting
Pharmacogenetics
Primary: Number of Patient Participants' Acceptance of PGx Services Offered in Community Pharmacy Setting — 14; 13 Participants
N/A N=102 Clinical Investigation of New CI Delivery Models in an Adult Nucleus CI Population
Sensorineural Hearing Loss, Bilateral · Cochlear Implant
Primary: Change in Monosyllabic Word Recognition Scores (CNC) in Quiet — 13.9; 60.1; 60.2; 59.1 percentage of correct words
N/A N=66 Mobile Application to Enhance Medication Management
Medication Adherence · Mobile Application
Primary: Usability of the SAM App — 1.14; 1.32; 1.35; 1.81 score on a scale
N/A N=1,509 Automated Hovering to Improve Medication Adherence Among Myocardial Infarction Patients (Heartstrong)
Patients With Principal or Secondary Diagnosis Code of Intrntl Classification of Diseases, 9th Revision, (ICD-9-CM) 410 (Except When 5th Digit Was 2)
Primary: 1 -Year Survival Probability Rate: Vascular Readmissions or Death — .91; .91 proportion of participants
N/A N=301 IntelliCare Study: Artificial Intelligence in a Mobile (AIM) Intervention for Depression
Depression · Anxiety
Primary: Adherence to the Mobile Application Intervention — 56; 56; 56; 56 days — p=0.3
Phase 4 N=326 Medication Abortion Via Pharmacy Dispensing
Pregnancy Related · Abortion Early
Primary: Number of Pharmacists Who Objected to Participate in Dispensing Mifeprex — 4 Participants
N/A N=39 Managing Insulin With a Voice AI
Medication Adherence
Primary: Time to Optimal Insulin Dose — 56; 15 days — p=0.006
N/A N=862 Pharmacist Intervention to Decrease Medication Errors in Heart Disease Patients (The PILL-CVD Study)
Acute Coronary Syndrome · Heart Failure
Primary: Number of Serious Medication Errors as Determined by Interview and Medical Chart Review — 0.95; 0.87 serious medication errors
N/A N=52 The Medication Metronome Project - Study to Facilitate Follow-up Testing Resulting From Prescribed Medications to Improve Patient Safety and Care
Diabetes Mellitus, Type 2 · Hypertension · Hyperlipidemia
Primary: Primary Effectiveness Outcome - LDL — 57.9; 54.8 percentage of time spent at goal
N/A N=105 IntelliCare: Artificial Intelligence in a Mobile Intervention for Depression and Anxiety (AIM)
Major Depressive Disorder · Anxiety Disorders
Primary: Patient Health Questionnaire - 9 (PHQ-9) - Depression Severity Module — 12.5; 8.4; 6.4 units on a scale — p=<.001
N/A N=258 Pharmacy-based Interdisciplinary Program for Patients With Chronic Heart Failure
Chronic Heart Failure
Primary: Medication Adherence — 91.2; 85.5 percentage of days covered
N/A N=156 Eliminating Risk of Preventable Adverse Drug Events at the Hospital-community Interface of Care
Adverse Drug Events
Primary: Health Services Utilization 3 Months Following Hospital Discharge — 3.33; 3.40 Health Services Utilizations — p=.87
N/A N=119 Development & Pilot of the Technology-Enabled Alliance for Medication Therapy Management
Polypharmacy
Primary: Medication Reconciliation — 0.14; 0.17 number of discrepancies per medication
N/A N=117,649 Encouraging Flu Vaccination Among High-Risk Patients Identified by ML
Influenza · Vaccination · Health Promotion
Primary: Flu Vaccination Rate — 4901; 5042; 5087; 5090 Participants — p=0.0035
N/A N=91 Pharmacy Home Adherence Reporting and Monitoring Outcomes Study
Diabetes · Hypertension · Hypercholesterolemia
Primary: Probability of Resolution of Nonadherence Within 30 Days — .4286; .4290; .4554; .4437 Proportion of resolved NAEs within 30 — p=<0.01
N/A N=40 New Patient Support Program in Type 2 Diabetes
Diabetes Mellitus, Type 2
Primary: Percent of Participants With Adherence to the PDTA — 98; 98; 98 percentage of participants
N/A N=62 Intelligent Control Approach to Anemia Management
End-Stage Renal Disease
Primary: Percent Hb 10-12 g/dL — 61.9; 72.5 Percent
N/A N=28 Piloting Healthcare Coordination in Hypertension
Hypertension
Primary: Clinical Adoption of a Decision Support Artificial Intelligence — 10; 3 Participants
N/A N=22 Learning and Improving Alzheimer's Patient-Caregiver Relationships Via Smart Healthcare Technology
Alzheimer Disease · Caregiver Stress Syndrome
Primary: Depression Anxiety Stress Scale (DASS) — 26.27; 29.10; 8.09; 10 score on a scale — p=0.444
N/A N=10 Pharmacist Provision of Medication Abortion
Abortion in First Trimester
Primary: Completion of Medication Abortion — 9 Participants
N/A N=100 Impact of Pharmaceutical Care in Diabetics Patients
Diabetes Mellitus Type 2
Primary: Glycated Hemoglobin — 7.2; 7.1 percent (%)
N/A N=179 Pharmaceutical Care Program for Pharmacological Treatment of Depression in Primary Care
Depression
Primary: Adherence to Antidepressant Medication — 78.4; 61.9; 60.1; 40.2 percentage of adherence patients
N/A N=24 RxConnect User Testing Study
Behavior
Primary: Number of Prescribing Errors by Study Arm — 8; 34; 8; 31 Medication orders